Company Financials

Hanmi Pharm. Co. Ltd Financials

South Korean won

business Hanmi Pharm. Co. Ltd Company Profile

Main Stock Listing

KRX: 128940

Market Capitalization ₩3.633 Trillion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jul. 4, 2025

Trailing PE
Forward PE 22.58
Price to Sales TTM ₩2.45
Price to Book MRQ
Enterprise to Revenue 2.72
Enterprise to EBITDA 13.80

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-03-31
Profit Margin 7.35%
Operating Margin 15.10%
Return on Assets TTM 6.16%
Return on Equity TTM 10.01%

Income Statement

Revenue TTM ₩1,482,765,238,272
Revenue per Share TTM ₩116935.38
Quarterly Revenue Growth -3.20%
Gross Profit TTM ₩804,141,924,352
EBITDA ₩419,555,837,970
Net Income to Common TTM ₩108,918,587,392
Diluted EPS TTM
Quarterly Earnings Growth YoY -22.50%

Balance Sheet

Total Cash MRQ ₩218,528,169,984
Total Cash per Share MRQ ₩17233.79
Total Debt MRQ
Total Debt to Equity MRQ 37.22
Current Ratio MRQ 1.16
Book Value per Share MRQ

Cash Flow

Operating Cash Flow TTM ₩145,110,286,336
Levered Free Cash Flow TTM ₩86,277,914,624

128940 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding 12,680,214
Float Shares 6,201,766
Avg 10 Volume 59,956
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 50.56%
% Held by Institutions 19.38%

Stock Price Summary

Beta 0.68
Fifty Two Week Low ₩214500.00
Fifty Two Week High ₩375000.00
Fifty Two Week Change 1.41%
Day 50 MA ₩283980.00
Day 200 MA ₩278042.50

Dividends and Splits

Forward Annual Dividend Rate ₩4000.00
Forward Annual Dividend Yield 1.41%
Trailing Annual Dividend Rate ₩1000.00
Trailing Annual Dividend Yield 0.35%
Payout Ratio 14.55%
Dividend Date
Ex Dividend Date 2024-12-27
Last Split Factor
Last Split Date 2023-12-27